1. Home
  2. VIR vs REAX Comparison

VIR vs REAX Comparison

Compare VIR & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • REAX
  • Stock Information
  • Founded
  • VIR 2016
  • REAX 2018
  • Country
  • VIR United States
  • REAX United States
  • Employees
  • VIR N/A
  • REAX N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • REAX
  • Sector
  • VIR Health Care
  • REAX
  • Exchange
  • VIR Nasdaq
  • REAX Nasdaq
  • Market Cap
  • VIR 844.9M
  • REAX 909.7M
  • IPO Year
  • VIR 2019
  • REAX N/A
  • Fundamental
  • Price
  • VIR $5.41
  • REAX $4.32
  • Analyst Decision
  • VIR Strong Buy
  • REAX Strong Buy
  • Analyst Count
  • VIR 7
  • REAX 2
  • Target Price
  • VIR $33.57
  • REAX $6.00
  • AVG Volume (30 Days)
  • VIR 1.0M
  • REAX 760.0K
  • Earning Date
  • VIR 05-07-2025
  • REAX 05-08-2025
  • Dividend Yield
  • VIR N/A
  • REAX N/A
  • EPS Growth
  • VIR N/A
  • REAX N/A
  • EPS
  • VIR N/A
  • REAX N/A
  • Revenue
  • VIR $20,861,000.00
  • REAX $1,417,877,000.00
  • Revenue This Year
  • VIR N/A
  • REAX $38.54
  • Revenue Next Year
  • VIR $10.65
  • REAX $17.98
  • P/E Ratio
  • VIR N/A
  • REAX N/A
  • Revenue Growth
  • VIR N/A
  • REAX 81.30
  • 52 Week Low
  • VIR $4.95
  • REAX $3.55
  • 52 Week High
  • VIR $14.45
  • REAX $6.75
  • Technical
  • Relative Strength Index (RSI)
  • VIR 35.98
  • REAX 45.73
  • Support Level
  • VIR $5.83
  • REAX $4.05
  • Resistance Level
  • VIR $6.29
  • REAX $4.99
  • Average True Range (ATR)
  • VIR 0.31
  • REAX 0.21
  • MACD
  • VIR 0.02
  • REAX -0.02
  • Stochastic Oscillator
  • VIR 28.80
  • REAX 28.72

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: